|
|
| A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
Integrated Screen, Part 1
Test CodeIS1
Alias/See Also
Maternal Integrated Screen, Specimen 1
Includes
This test will be reported and billed with Maternal Serum Integrated Screen, Part 2 results.
Preferred Specimen
1.5 mL serum
Minimum Volume
0.8 mL
Transport Container
Transport tube
Transport Temperature
Room temperature
Specimen Stability
Room temperature: 7 days
Refrigerated: 7 days
Refrigerated: 7 days
Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)
Gross Hemolysis and Lipemia
Methodology
Chemiluminescence (CL) • Immunoassay (IA)
FDA Status
This test code is for non-New York patient testing. For New York patient testing, use test code 16976.
This test is not available for California patient testing.
Setup Schedule
Performed by University of Iowa Hygienic Lab Monday-Friday
Report Available
Reports in 5-9 days
Limitations
Refer to Integrated Screen, Part 2
Reference Range
See Laboratory Report
Clinical Significance
To assess maternal risk for carrying a fetus with Down Syndrome (Trisomy 21), Trisomy 18, or a neural tube defect. These types of tests are standard-of-care in obstetrics.
